Investigators
Find a Member
Results

Ahmad Tafti
Program: Cancer Therapeutics
Summary
I am an Assistant Professor of Health Informatics in the Department of Health Information Management within the School of Health and Rehabilitation Sciences at the University of Pittsburgh, with a secondary appointment at the Intelligent Systems Program (ISP). I am also leading our efforts at the Pitt HexAI Research Laboratory. I am also affiliated with the Center for AI Innovation in Medical Imaging (CAIIMI). Starting from August 2022, I am honored to serve our community as the Vice Chair of IEEE Computer Society at Pittsburgh. I have a deep passion for…
Evelyn Talbott
Program: Cancer Epidemiology and Prevention
Summary
Dr. Talbott's areas of expertise are in environmental and cardiovascular epidemiology. Dr. Talbott has worked closely with both state and local health departments to conduct health studies investigating potential linkage of environmental exposures and health effects.
Kelly Tan
Program: Biobehavioral Cancer Control
Summary
My current cancer-related research focuses on caregivers or people with advanced cancer, stress response, cancer outcomes and symptom science. I have a currently funded study of LGBT+ Cancer caregivers.
Curtis Tatsuoka
Program: Cancer Epidemiology and Prevention
Summary
Dr. Tatsuoka is Professor of Medicine and he co-directs the Biostatistics Facility at Hillman. He provides biostatistical expertise for data analysis, clinical trial and study design, and grant preparation. He has a broad collaborative background. His own methodological research has been and is currently funded by NSF and NIH, and his interests include adaptive experimental designs, such as in clinical trials and classification analyses, high performance computing, and imaging…
D Lansing Taylor
Program: Cancer Therapeutics
Summary
My research has been rooted in developing and applying new technologies involving “high content” imaging methods to biomedical challenges. We have been applying quantitative systems pharmacology (QSP) to multiple disease areas including liver diseases and solid tumor cancers. My interests include integrating QSP with patient microphysiology systems (MPS) to generate pathophysiological experimental and computational models to create a powerful paradigm in drug discovery and development. The latter has led to developing patient digital twins and patient biomimetic twins for liver…
Sarah Taylor
Program: Cancer Therapeutics
Summary
Dr. Taylor’s research interests include targeted and novel treatments of gynecologic cancer, correlated biomarker development for defining personalized cancer therapy, and screening and early detection of gynecologic cancers, particularly in individuals with hereditary predisposition to cancer. Her collaborations extend to colleagues within the Women’s Cancer Research Group at the University of Pittsburgh School of Nursing. As an interdisciplinary team of researchers, their focus is on overlapping research interests regarding patients’ quality of life, health services…
Lauren Terhorst
Program: Biobehavioral Cancer Control
Summary
Lauren Terhorst is a professor in the Department of Occupational Therapy with secondary appointments in the School of Nursing and the Clinical and Translational Science Institute. She is also the co-director of the SHRS Data Center. Her primary area of expertise is related to applications of statistical methodology in health science research. She is a co-investigator and biostatistician on several grants from agencies such as the National Institutes of Health and Patient Centered Outcomes Research Institute (PCORI). She serves as a reviewer for peer-reviewed journals and national funding…
Jean Tersak
Program: Biobehavioral Cancer Control
Summary
Dr. Tersak is board-certified in Pediatric Hematology/Oncology. She provides care for pediatric oncology patients and long term survivors of childhood cancer. She is extensively involved in clinical research including the evaluation and treatment of patients with new diagnosis and research in the area of medical late effects and quality of life in childhood cancer survivors.
Gary Thomas
Program: Cancer Biology
Summary
We investigate signaling pathways that integrate membrane traffic with the regulation of homeostasis and the onset of disease, including cancer and autism, and we leverage these discoveries to develop targeted therapies. Our studies are grounded by our discovery of the PACS family of multi-functional sorting proteins. Currently, we are investigating how the PACS proteins regulate key deacetylases, including SIRT1 and HDAC6, to control signaling pathways impacting cancer cell death, obesity, and neurodevelopmental…
Teresa Thomas
Program: Biobehavioral Cancer Control
Summary
Dr. Thomas is a leader in promoting self-advocacy among patients with cancer. She has developed a model and measure of how patients advocate for their needs and priorities within the context of their cancer experience – the Self-Advocacy in Cancer Survivorship Model. Currently, her research evaluates the impact of a theoretically-based, patient-centered serious game (a motivational video game) intervention on women with advanced cancer’s self-advocacy skills, symptom burden, and use of health care services (R37CA262025 - NCT04813276). She also works with clinical nurses to…
Meghan Tipre
Program: Biobehavioral Cancer Control
Summary
My research interests focus on studying the relationship between environmental hazards and cancer, examining whether socio-cultural, biological, and behavioral determinants may mediate or moderate these relationships. I use a broad toolkit of research methods, including quantitative and qualitative methods, geographic information systems (GIS), and spatial statistics, to characterize risk factors and test…
Mohamed Trebak
Program: Cancer Biology
Summary
I am an ion channel physiologist with long term interests in basic ion channel regulation and activation and the contributions of altered channel function to disease. I have been funded all my career by NHLBI, NIA and NIEHS and have developed strong interests in the contribution of ion channel dysfunction to cellular, molecular and metabolic remodeling in vascular proliferative diseases and lung obstructive diseases. Nevertheless, I have consistently maintained an interest in the nascent and exciting field of "ion channels and cancer". I have consistently had one postdoc (sometimes…
George Tseng
Program: Cancer Biology
Summary
Dr. George Tseng is Professor and Vice Chair for Research in the Departments of Biostatistics, School of Public Health, University of Pittsburgh. He also has secondary appointments in Human Genetics, and Computational and Systems Biology. He received BS (1997) and MS (1999) in Mathematics from the National Taiwan University under Dr. Hung Chen, and ScD (2003) in Biostatistics from the Harvard School of Public Health under Dr. Wing Hung Wong's lab. He joined Pitt since 2003 and leads a research group in Bioinformatics and Statistical Learning. His research interests focus on statistical…
Pradeep Tyagi
Program: Cancer Therapeutics
Summary
Dr. Tyagi’s research interests include application of intravesical drug delivery techniques and urinary biomarkers to advance the diagnosis and care of bladder cancer, prostate cancer, benign prostatic hyperplasia and interstitial cystitis/painful bladder syndrome.